31
War & Conflict3h 58m ago

Gland Pharma Limited’s Board approved the re-appointment of Mr. Udo Johannes Vetter for a second term and the appointment of Mr. William Robert Keller as an Independent Director, effective June 15, 2026.

Archive Window: 7 Days Left

not specified

Who
Mr. Udo Johannes Vetter, Mr. William Robert Keller, Mr. Satyanarayana Murthy Chavali, Mr. Essaji Goolam Vahanvati, Gland Pharma Limited
What
Gland Pharma Limited’s Board approved the re-appointment of Mr. Udo Johannes Vetter for a second term and the appointment of Mr. William Robert Keller as an Independent Director, effective June 15, 2026.
When
Mon, 15 Jun 2026 21:48:44 GMT · 3h 58m ago
Where
not specified ·
Why
The appointments and re-appointments follow the resignation of Mr. Satyanarayana Murthy Chavali due to a potential conflict of interest, necessitating a reconstitution of Board committees.
The Frontline Impact

How this affects you

These changes reflect a shift in corporate governance at Gland Pharma, ensuring compliance with SEBI Listing Regulations and potentially influencing the company's strategic direction through new independent oversight.

Story chain

3 events in this thread

Verified Sources & Citations